Metabolites as risk factors for diabetic retinopathy in patients with type 2 diabetes: a 12-year follow-up study
L Fernandes Silva, J Hokkanen… - The Journal of …, 2024 - academic.oup.com
Context Diabetic retinopathy (DR) is a specific microvascular complication in patients with
diabetes and the leading cause of blindness. Recent advances in omics, especially …
diabetes and the leading cause of blindness. Recent advances in omics, especially …
[HTML][HTML] Metabolites as Risk Factors for Diabetic Retinopathy in Patients With Type 2 Diabetes: A 12-Year Follow-up Study
L Fernandes Silva, J Hokkanen… - The Journal of …, 2024 - academic.oup.com
Context Diabetic retinopathy (DR) is a specific microvascular complication in patients with
diabetes and the leading cause of blindness. Recent advances in omics, especially …
diabetes and the leading cause of blindness. Recent advances in omics, especially …
[PDF][PDF] Metabolites as Risk Factors for Diabetic Retinopathy in Patients With Type 2 Diabetes: A 12-Year Follow-up Study
LF Silva, J Hokkanen, J Vangipurapu, A Oravilahti… - 2023 - academia.edu
Context: Diabetic retinopathy (DR) is a specific microvascular complication in patients with
diabetes and the leading cause of blindness. Recent advances in omics, especially …
diabetes and the leading cause of blindness. Recent advances in omics, especially …
[HTML][HTML] Metabolites as Risk Factors for Diabetic Retinopathy in Patients With Type 2 Diabetes: A 12-Year Follow-up Study
LF Silva, J Hokkanen, J Vangipurapu… - The Journal of …, 2024 - ncbi.nlm.nih.gov
Methods We performed a 12-year follow-up study including 1349 participants with type 2
diabetes (1021 without DR, 328 with DR) selected from the METSIM cohort. Individuals who …
diabetes (1021 without DR, 328 with DR) selected from the METSIM cohort. Individuals who …
Metabolites as Risk Factors for Diabetic Retinopathy in Patients With Type 2 Diabetes: A 12-Year Follow-up Study.
J Hokkanen, J Vangipurapu, A Oravilahti… - The Journal of Clinical …, 2023 - europepmc.org
Methods We performed a 12-year follow-up study including 1349 participants with type 2
diabetes (1021 without DR, 328 with DR) selected from the METSIM cohort. Individuals who …
diabetes (1021 without DR, 328 with DR) selected from the METSIM cohort. Individuals who …
Metabolites as Risk Factors for Diabetic Retinopathy in Patients With Type 2 Diabetes: A 12-Year Follow-up Study
LF Silva, J Hokkanen, J Vangipurapu… - The Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Context Diabetic retinopathy (DR) is a specific microvascular complication in patients with
diabetes and the leading cause of blindness. Recent advances in omics, especially …
diabetes and the leading cause of blindness. Recent advances in omics, especially …
Metabolites as Risk Factors for Diabetic Retinopathy in Patients with Type 2 Diabetes: a 12-year Follow-up Study.
J Hokkanen, J Vangipurapu, A Oravilahti… - The Journal of Clinical …, 2023 - europepmc.org
Results We found 17 metabolites significantly associated with incident DR after the
adjustment for confounding factors. Among amino acids, N-lactoyl isoleucine, N-lactoyl …
adjustment for confounding factors. Among amino acids, N-lactoyl isoleucine, N-lactoyl …